News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
93,171 Results
Type
Article (6767)
Company Profile (39)
Press Release (86365)
Section
Business (27824)
Career Advice (134)
Deals (4002)
Drug Delivery (32)
Drug Development (14135)
Employer Resources (12)
FDA (2858)
Job Trends (2123)
News (49362)
Policy (6016)
Tag
2024 BioForest Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
2026 Pharm Country Premier (1)
Academia (427)
Accelerated approval (2)
Adcomms (7)
Allergies (30)
Alliances (9039)
ALS (13)
Alzheimer's disease (261)
Antibody-drug conjugate (ADC) (39)
Approvals (2861)
Artificial intelligence (39)
Autoimmune disease (8)
Automation (3)
Bankruptcy (19)
Best Places to Work (1805)
BIOSECURE Act (16)
Biosimilars (74)
Biotechnology (26)
Bladder cancer (20)
Brain cancer (6)
Breast cancer (50)
Cancer (435)
Cardiovascular disease (20)
Career advice (115)
Career pathing (4)
CAR-T (20)
Cell therapy (83)
Cervical cancer (3)
Clinical research (11513)
Collaboration (181)
Compensation (40)
Complete response letters (9)
COVID-19 (548)
CRISPR (5)
C-suite (48)
Cystic fibrosis (14)
Data (413)
Denatured (2)
Depression (5)
Diabetes (35)
Diagnostics (558)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (23)
Drug pricing (22)
Drug shortages (1)
Duchenne muscular dystrophy (25)
Earnings (9506)
Editorial (5)
Employer branding (3)
Employer resources (10)
Events (11879)
Executive appointments (115)
FDA (3185)
Featured Employer (9)
Frontotemporal dementia (1)
Funding (141)
Gene editing (24)
Generative AI (5)
Gene therapy (79)
GLP-1 (107)
Government (1309)
Grass and pollen (1)
Guidances (11)
Healthcare (1967)
Huntington's disease (2)
IgA nephropathy (2)
Immunology and inflammation (37)
Indications (8)
Infectious disease (581)
Inflammatory bowel disease (46)
Inflation Reduction Act (4)
Influenza (15)
Intellectual property (11)
Interviews (11)
IPO (1845)
IRA (13)
Job creations (389)
Job search strategy (111)
Kidney cancer (2)
Labor market (2)
Layoffs (55)
Legal (560)
Liver cancer (13)
Lung cancer (73)
Lymphoma (25)
Management (2)
Manufacturing (99)
MASH (10)
Medical device (1181)
Medtech (1182)
Mergers & acquisitions (2248)
Metabolic disorders (82)
Multiple sclerosis (16)
NASH (2)
Neurodegenerative disease (18)
Neuropsychiatric disorders (1)
Neuroscience (333)
NextGen: Class of 2025 (700)
Non-profit (353)
Northern California (465)
Now hiring (10)
Obesity (30)
Opinion (47)
Ovarian cancer (20)
Pain (8)
Pancreatic cancer (13)
Parkinson's disease (9)
Partnered (3)
Patents (29)
Patient recruitment (19)
Peanut (21)
People (8005)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase I (3792)
Phase II (4793)
Phase III (4220)
Pipeline (282)
Podcasts (6)
Policy (40)
Postmarket research (297)
Preclinical (1475)
Press Release (66)
Prostate cancer (16)
Psychedelics (5)
Radiopharmaceuticals (36)
Rare diseases (70)
Real estate (920)
Recruiting (4)
Regulatory (4770)
Reports (11)
Research institute (388)
Resumes & cover letters (13)
RNA editing (1)
RSV (10)
Schizophrenia (11)
Series A (33)
Series B (13)
Service/supplier (3)
Sickle cell disease (7)
Southern California (469)
Special edition (3)
Spinal muscular atrophy (21)
Sponsored (9)
Startups (574)
State (1)
Stomach cancer (3)
Supply chain (9)
Tariffs (2)
The Weekly (4)
United States (4002)
Vaccines (184)
Venture capitalists (4)
Webinars (1)
Weight loss (14)
Women's health (3)
Date
Today (18)
Last 7 days (154)
Last 30 days (548)
Last 365 days (6366)
2025 (1652)
2024 (6525)
2023 (6986)
2022 (9103)
2021 (9534)
2020 (8227)
2019 (5875)
2018 (4539)
2017 (5064)
2016 (4628)
2015 (5280)
2014 (3732)
2013 (2904)
2012 (2995)
2011 (3158)
2010 (2580)
Location
Africa (92)
Alabama (11)
Alaska (1)
Arizona (12)
Arkansas (2)
Asia (7510)
Australia (885)
California (1103)
Canada (227)
China (167)
Colorado (32)
Connecticut (26)
Delaware (37)
Europe (13857)
Florida (128)
Georgia (18)
Idaho (13)
Illinois (45)
India (11)
Indiana (39)
Iowa (1)
Japan (27)
Kansas (3)
Kentucky (9)
Louisiana (2)
Maine (5)
Maryland (313)
Massachusetts (754)
Michigan (23)
Minnesota (44)
Mississippi (1)
Missouri (14)
Montana (5)
Nebraska (6)
Nevada (4)
New Hampshire (3)
New Jersey (438)
New Mexico (4)
New York (307)
North Carolina (193)
North Dakota (7)
Northern California (465)
Ohio (39)
Oklahoma (7)
Oregon (2)
Pennsylvania (185)
Puerto Rico (1)
Rhode Island (5)
South America (134)
South Carolina (2)
Southern California (469)
Tennessee (3)
Texas (142)
Utah (24)
Virginia (16)
Washington D.C. (6)
Washington State (87)
Wisconsin (8)
93,171 Results for "rucdr infinite biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Theriva™ Biologics to Present at the 2025 NeauxCancer Conference
March 20, 2025
·
2 min read
Press Releases
FairJourney Biologics Establishes Supervisory Board
March 25, 2025
·
4 min read
Pharm Country
RUCDR Infinite Biologics Becomes Infinity BiologiX
Company spins off from Rutgers University to strengthen its impact and leadership position as a Next-Generation Central Laboratory
August 19, 2020
·
5 min read
Press Releases
Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
April 1, 2025
·
9 min read
Press Releases
ViroCell Biologics Appoints Viral Vector Expert as Special Advisor
March 27, 2025
·
2 min read
Press Releases
Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development
January 19, 2025
·
4 min read
Press Releases
Qu Biologics’ Immunomodulator Clears Senescence
February 11, 2025
·
5 min read
Press Releases
GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2025
March 17, 2025
·
4 min read
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
·
1 min read
·
BioSpace Insights
1 of 9,318
Next
